IDG Capital Backs Shenzhen-Based Biotech Firm Yuce Bio In Series B Round

Login to View

Shenzhen-based Biotech firm Yuce Biological Technology has completed a series B round led by IDG Capital, as biotech booms in China.

Continue reading with a China Money Network subscription

Join Now

Already have an account or paid subscription? Log in